[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 2004

The Utility of Antihistone Antibody Screening in the Diagnosis of Drug-Induced Lupus Erythematosus

Arch Dermatol. 2004;140(4):494-495. doi:10.1001/archderm.140.4.494

Antihistone antibodies (AHAs) are classically associated with drug-induced lupus erythematosus.1 However, multiple studies have revealed that AHAs are present with significant frequency in several other autoimmune diseases, including systemic lupus erythematosus unrelated to medications, rheumatoid arthritis, juvenile rheumatoid arthritis, primary biliary cirrhosis, autoimmune hepatitis, dermatomyositis/polymyositis, and scleroderma.2,3

First Page Preview View Large
First page PDF preview
First page PDF preview